265 results
Page 4 of 14
8-K
EX-99.1
pyrf98b9
11 Jan 21
Axogen Reports Preliminary Unaudited Revenue
7:15am
8-K
EX-99.2
m49i4hqig
11 Jan 21
Axogen Reports Preliminary Unaudited Revenue
7:15am
424B3
exj69m3ihy2tioa fwwh
8 Jan 21
Prospectus supplement
5:29pm
8-K
EX-10.1
odvxkxymttn gt5dbtr
6 Jan 21
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.6
szqh0uu2kb cowic3
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.4
0yq1csx
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-99.1
r34gz2
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.1
9opctrpfx6dztrs1d
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.3
ssg 3d6rlu7mqnv
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.7
d4j5tjp chc
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.2
z238ackj01hj
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
EX-10.5
2gk3c6o 82
29 Oct 20
Axogen, Inc. Reports Third Quarter 2020 Financial Results
5:02pm
8-K
dnq5k3 77w
15 Sep 20
Regulation FD Disclosure
4:12pm
8-K
EX-99.1
odjk 9c0sy6
22 Jul 20
Axogen RECONSM Clinical Study Completes Target Enrollment of 220 Subjects
7:11am
8-K
EX-99.1
igt1xk
1 Jul 20
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
7:11am
8-K
EX-10.2
jyi0r
1 Jul 20
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
7:11am
8-K
EX-10.1
9tf1g y84ux
1 Jul 20
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
7:11am